NasdaqCM - Nasdaq Real Time Price USD
Celldex Therapeutics, Inc. (CLDX)
19.49
+0.06
+(0.31%)
As of 12:34:05 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CAVANAUGH SARAH Officer | Conversion of Exercise of derivative security | May 30, 2024 | 1,860 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security | Jun 14, 2024 | 9,074 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security | Jun 3, 2024 | 13,383 |
| JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security | Jun 5, 2024 | 35,464 |
| MARINO JAMES J Director | Stock Gift | Nov 18, 2024 | 2,204 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security | Jun 14, 2024 | 28,125 |
| WRIGHT RICHARD M Officer | Conversion of Exercise of derivative security | Jun 3, 2024 | 20,833 |
| YOUNG DIANE C Officer | Conversion of Exercise of derivative security | Jun 11, 2024 | 17,115 |
Related Tickers
FOLD Amicus Therapeutics, Inc.
7.12
+0.21%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.0838
0.00%
ACAD ACADIA Pharmaceuticals Inc.
14.70
+0.51%
SNDX Syndax Pharmaceuticals, Inc.
13.09
+0.65%
BCYC Bicycle Therapeutics plc
8.45
-2.55%
PTGX Protagonist Therapeutics, Inc.
45.45
-1.55%
KPTI Karyopharm Therapeutics Inc.
6.02
-4.01%
CYTK Cytokinetics, Incorporated
40.31
+6.07%
AKRO Akero Therapeutics, Inc.
41.09
+3.74%
INCY Incyte Corporation
58.52
+0.90%